SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is generating significant momentum driven by anticipation of its first halving event and recent institutional filings for a spot ETF. The community is heavily focused on TAO's role in decentralized AI infrastructure, with many investors actively discussing long-term growth potential and comparing its scarcity model to Bitcoin.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased community chatter as traders react to anticipation surrounding the upcoming Goliath mainnet launch and ongoing speculation regarding potential institutional ties. While bulls are focused on accumulation and breakout patterns, skeptics are expressing frustration over historical price volatility and questioning the lack of confirmed commercial partnerships.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending as institutional interest surges following recent ETF inflows and whale accumulation, with community members closely tracking key resistance levels near $13-$14. Market participants are primarily focused on the project's foundational role in RWA tokenization and upcoming legislative catalysts, viewing the current price as an accumulation opportunity despite lingering frustrations over volatility.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending as investors digest significant regulatory approvals, including EPA authorization and EU/UK REACH registrations, which signal a transition toward revenue-generating commercial operations. The community is actively debating the stock's potential for a NASDAQ uplisting and massive long-term scaling in sectors like defense and tech, while simultaneously tracking high short interest and FINRA Threshold List activity that is driving speculation about mandatory forced buying.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending following its Q4 2025 earnings report, which highlighted strong IBSRELA revenue growth and increased 2026 operating expenses, dividing community opinion while insider buying and a new LPGA partnership add to the conversation.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly remains at the center of investor focus as it maintains a dominant position in the obesity and diabetes market, with the community actively tracking the upcoming FDA decision for its oral GLP-1 candidate, orforglipron. Market sentiment remains heightened by ongoing debates regarding the company's competitive standing against Novo Nordisk and the broader impact of increasing regulatory scrutiny on the wider telehealth and compounding sector.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust is trending as the community debates whether the asset has found a bottom amidst heightened volatility, with many investors actively rebalancing their positions while weighing macroeconomic uncertainties against long-term bullish theses.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstone is trending as market attention focuses on its pivotal role in the private credit sector, where investors are closely monitoring redemption activity and loan quality amidst industry-wide turbulence. The community is actively debating the firm's resilience and long-term potential as it shifts capital toward AI-driven infrastructure and strategic asset exits, balancing concerns over liquidity against the firm's significant dry powder and market dominance.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is generating significant buzz as investors track an imminent FDA decision on its ADHD candidate, CTx-1301, with a target date of May 31, 2026. The community is heavily focused on potential catalysts like upcoming US patent news and the possibility of a buyout, with many long-term shareholders actively accumulating shares and debating the firm's valuation relative to the broader ADHD market.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile ($TMUS) is trending as investors weigh strong demand for new smartphone releases against a technical consolidation phase and competitive pressures within the telecom sector. The community is actively debating the stock's risk-reward profile, with many focusing on institutional accumulation, potential institutional upgrades, and the company's long-term competitive positioning compared to sector peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equillium (NASDAQ:EQ) Raised to "Hold" at Wall Street Zen

Wall Street Zen raised Equillium from a "sell" rating to a "hold" rating in a report on Saturday...

Roth Mkm Initiates Coverage on Equillium (NASDAQ:EQ)

Roth Mkm initiated coverage on Equillium in a research note on Friday. They set a "buy" rating and a $12.00 target price for the company...

Equillium, Inc. (NASDAQ:EQ) Given Average Recommendation of "Hold" by Brokerages

Equillium, Inc. (NASDAQ:EQ - Get Free Report) has earned a consensus rating of "Hold" from the five brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has...

Insider Selling: Equillium (NASDAQ:EQ) COO Sells 181,219 Shares of Stock

Equillium, Inc. (NASDAQ:EQ - Get Free Report) COO Christine Zedelmayer sold 181,219 shares of the company's stock in a transaction on Monday, March 9th. The shares were sold at an average price of...

Equillium (NASDAQ:EQ) COO Sells $362,438.00 in Stock

Equillium, Inc. (NASDAQ:EQ - Get Free Report) COO Christine Zedelmayer sold 181,219 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $2.00...

Short Interest in Equillium, Inc. (NASDAQ:EQ) Expands By 47.0%

Equillium, Inc. (NASDAQ:EQ - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 1,965,458 shares...

Equillium (NASDAQ:EQ) Stock Rating Upgraded by Zacks Research

Zacks Research raised shares of Equillium to a "hold" rating in a research report on Thursday...

Equillium (NASDAQ:EQ) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen downgraded shares of Equillium from a "hold" rating to a "sell" rating in a research report on Saturday...

Stifel Nicolaus Initiates Coverage on Equillium (NASDAQ:EQ)

Stifel Nicolaus started coverage on shares of Equillium in a research note on Wednesday. They set a "buy" rating and a $5.00 price objective on the stock...

Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 185,937 Shares

Equillium, Inc. (NASDAQ:EQ - Get Free Report) COO Christine Zedelmayer sold 185,937 shares of the company's stock in a transaction on Thursday, February 19th. The stock was sold at an average price...

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.06	--	--	N/A
Q3 '25	-$0.07	-$0.06	14.29%	BEAT
Q2 '25	-$0.16	-$0.16	--	EXPECTED
Q1 '25	-$0.34	--	--	N/A
Q4 '24	-$0.31	-$0.16	48.39%	BEAT

EQ
Equillium Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest EQ News

EQEquillium Inc